The granting of emergency use designation to COVID-19 candidate vaccines: implications for COVID-19 vaccine trials
An efficacious COVID-19 vaccine is currently the world's leading research priority. Several nations have indicated they would be prepared to authorize emergency use or conditional approval on public health grounds if there is a compelling case for use of a vaccine before it is licensed. candidate vaccines attain emergency use designation and be programmatically deployed before their phase 3 trials conclude, such a strategy could have far reaching consequences for COVID-19 vaccine research and th
